These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19133606)

  • 1. Management of a patient with borderline resectable pancreatic cancer. Case report and review.
    Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA
    Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
    Lluís F
    Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant strategies for pancreatic cancer.
    Evans DB; Wolff RA; Crane CH
    Oncology (Williston Park); 2001 Jun; 15(6):727-37; discussion 741-4, 747. PubMed ID: 11430206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
    Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
    Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
    Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
    Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
    J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer.
    Vento P; Mustonen H; Joensuu T; Kärkkäinen P; Kivilaakso E; Kiviluoto T
    World J Gastroenterol; 2007 Jun; 13(21):2945-51. PubMed ID: 17589944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for pancreatic and periampullary cancer.
    Tandon V
    Trop Gastroenterol; 2000; 21(3):129-30. PubMed ID: 11084835
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.
    Breslin TM; Hess KR; Harbison DB; Jean ME; Cleary KR; Dackiw AP; Wolff RA; Abbruzzese JL; Janjan NA; Crane CH; Vauthey JN; Lee JE; Pisters PW; Evans DB
    Ann Surg Oncol; 2001 Mar; 8(2):123-32. PubMed ID: 11258776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
    Evans DB; Varadhachary GR; Crane CH; Sun CC; Lee JE; Pisters PW; Vauthey JN; Wang H; Cleary KR; Staerkel GA; Charnsangavej C; Lano EA; Ho L; Lenzi R; Abbruzzese JL; Wolff RA
    J Clin Oncol; 2008 Jul; 26(21):3496-502. PubMed ID: 18640930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment strategies for pancreatic cancer.
    Newman EA; Simeone DM; Mulholland MW
    J Gastrointest Surg; 2006 Jun; 10(6):916-26. PubMed ID: 16769552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.
    Hoffman JP
    Ann Surg; 2000 Nov; 232(5):726-7. PubMed ID: 11066156
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.
    Evans DB; Wolff RA; Hess KR
    Ann Surg; 2000 Nov; 232(5):727. PubMed ID: 11066157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial).
    Maurel J; Sánchez-Cabús S; Laquente B; Gaba L; Visa L; Fabregat J; Povés I; Roselló S; Díaz-Beveridge R; Martín-Richard M; Rodriguez J; Sabater L; Conill C; Cambray M; Reig A; Ayuso JR; Valls C; Ferrández A; Bombí JA; Ginés A; García-Albéniz X; Fernández-Cruz L
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):935-943. PubMed ID: 30225601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer.
    Thanikachalam K; Damarla V; Seixas T; Dobrosotskaya I; Wollner I; Kwon D; Winters K; Raoufi M; Li J; Siddiqui F; Khan G
    Am J Clin Oncol; 2020 Jun; 43(6):435-441. PubMed ID: 32251119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy following surgery for periampullary and pancreatic cancers.
    Sonkar AA; Poston GJ
    Eur J Surg Oncol; 2004 Nov; 30(9):911-2. PubMed ID: 15498632
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.
    Hoffman JP; Cooper HS; Young NA; Pendurthi TK
    J Hepatobiliary Pancreat Surg; 1998; 5(3):251-4. PubMed ID: 9880771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
    Maisonneuve P; Lowenfels AB
    JAMA; 2007 Jun; 297(23):2581; author reply 2582. PubMed ID: 17579223
    [No Abstract]   [Full Text] [Related]  

  • 20. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.